AJOVista LLC Takes Position in The Cigna Group (NYSE:CI)

AJOVista LLC acquired a new stake in The Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 383 shares of the health services provider’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Roman Butler Fullerton & Co. increased its holdings in The Cigna Group by 61.4% in the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock worth $2,772,000 after acquiring an additional 3,539 shares in the last quarter. Ellsworth Advisors LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth about $4,377,000. Sapient Capital LLC acquired a new stake in The Cigna Group in the 4th quarter worth about $2,811,000. Allspring Global Investments Holdings LLC increased its stake in The Cigna Group by 29.5% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock worth $87,870,000 after buying an additional 66,891 shares in the last quarter. Finally, Accurate Wealth Management LLC acquired a new position in shares of The Cigna Group during the fourth quarter valued at approximately $2,244,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the transaction, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other The Cigna Group news, CEO David Cordani sold 38,065 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the transaction, the chief executive officer now owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Eric P. Palmer sold 1,017 shares of the company’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.26, for a total value of $340,959.42. Following the sale, the insider now directly owns 45,564 shares in the company, valued at approximately $15,275,786.64. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 114,144 shares of company stock worth $39,296,330. 0.60% of the stock is currently owned by company insiders.

The Cigna Group Trading Down 0.9 %

Shares of NYSE CI traded down $3.00 during mid-day trading on Friday, reaching $341.50. 2,413,548 shares of the company’s stock were exchanged, compared to its average volume of 1,380,653. The firm has a market capitalization of $99.84 billion, a price-to-earnings ratio of 28.04, a PEG ratio of 1.05 and a beta of 0.57. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company’s 50-day moving average is $350.77 and its 200-day moving average is $319.59. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.67 and a current ratio of 0.71.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business had revenue of $57.25 billion during the quarter, compared to analysts’ expectations of $56.59 billion. During the same period last year, the business earned $5.41 earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Analysts expect that The Cigna Group will post 28.4 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be paid a $1.40 dividend. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.64%. The Cigna Group’s payout ratio is presently 45.98%.

Analyst Upgrades and Downgrades

Several analysts recently commented on CI shares. StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Thursday, March 14th. Mizuho boosted their price target on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Oppenheimer increased their price objective on shares of The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Friday. Cantor Fitzgerald boosted their target price on The Cigna Group from $384.00 to $400.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Royal Bank of Canada raised The Cigna Group from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $327.00 to $354.00 in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $366.14.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.